Showing results (121-130 of 146) with videos related to
Sort By:
Pageof 15
Science Advances|December 17, 2019
Identification of TNFR2 and IL-33 as therapeutic targets in localized fibrosisDavid Izadi, Thomas B Layton, Lynn Williams, et al.Arthritis Research & Therapy|March 21, 2008
Resting CD4+ effector memory T cells are precursors of bystander-activated effectors: a surrogate model of rheumatoid arthritis synovial T-cell functionFionula M Brennan, Nicola M G Smith, Sally Owen, et al.Proceedings of the National Academy of Sciences of the United States of America|January 29, 2014
OX40L blockade is therapeutic in arthritis, despite promoting osteoclastogenesisEmily Gwyer Findlay, Lynett Danks, Jodie Madden, et al.Journal of Medicinal Chemistry|April 14, 2023
Novel Synthesis of C-Methylated Phytocannabinoids Bearing Anti-inflammatory PropertiesYarden Lavi, Natalya M Kogan, Louise M Topping, et al.The Journal of Biological Chemistry|January 6, 2018
Inhibition of histone H3K27 demethylases selectively modulates inflammatory phenotypes of natural killer cellsAdam Cribbs, Edward S Hookway, Graham Wells, et al.Molecular Medicine (Cambridge, Mass.)|May 23, 2007
Molecular profile of peripheral blood mononuclear cells from patients with rheumatoid arthritisChristopher J Edwards, Jeffrey L Feldman, Jonathan Beech, et al.Nature Communications|June 4, 2020
Cellular census of human fibrosis defines functionally distinct stromal cell types and statesThomas B Layton, Lynn Williams, Fiona McCann, et al.Nature Communications|June 26, 2020
Author Correction: Cellular census of human fibrosis defines functionally distinct stromal cell types and statesThomas B Layton, Lynn Williams, Fiona McCann, et al.Scientific Reports|June 3, 2020
Novel biomarkers of a peripheral blood interferon signature associated with drug-naïve early arthritis patients distinguish persistent from self-limiting disease courseAttila A Seyhan, Bernard Gregory, Adam P Cribbs, et al.Proceedings of the National Academy of Sciences of the United States of America|April 6, 2022
COVID-19 therapeutics: Challenges and directions for the futurePhilip C Robinson, David F L Liew, Helen L Tanner, et al.Pageof 15